1. Chemotherapy toxicity prevention

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Hospitalisation following tolmetin administration

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. Beta blocker poisoning

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Acetyldigoxin overdose

   Newsletter Article 05 February 2013 Pages: 4 - 4

5. Amantadine

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Amikacin/gentamicin

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Amodiaquine

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Anticoagulants

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Antineoplastics

   Newsletter Article 05 February 2013 Pages: 4 - 4

10. Antipsychotics

    Newsletter Article 05 February 2013 Pages: 4 - 5

11. Antipsychotics withdrawal

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Antitussives see Phenelzine interaction

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Aspirin

    Newsletter Article 05 February 2013 Pages: 5 - 5

14. Auranofin

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Aurothiopropanol

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Buprenorphine

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Buspirone

    Newsletter Article 05 February 2013 Pages: 5 - 5

18. Chlorphenamine +; phenylpropanolamine see Cocaine interaction

    Newsletter Article 05 February 2013 Pages: 5 - 5

19. Cinnarizine/flunarizine

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Clofazimine

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Clomifene

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Cocaine interaction

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Contraceptives, oral

    Newsletter Article 05 February 2013 Pages: 6 - 6

24. Contrast media

    Newsletter Article 05 February 2013 Pages: 6 - 6

25. Cyclosporin interaction

    Newsletter Article 05 February 2013 Pages: 7 - 7

26. Cyproterone

    Newsletter Article 05 February 2013 Pages: 7 - 7

27. Dapsone

    Newsletter Article 05 February 2013 Pages: 7 - 7

28. Enalapril see Lithium interaction

    Newsletter Article 05 February 2013 Pages: 7 - 7

29. Etretinate see Isotretinoin/etretinate

    Newsletter Article 05 February 2013 Pages: 7 - 7

30. Fluconazole see Cyclosporin interaction

    Newsletter Article 05 February 2013 Pages: 7 - 7

31. Flunarizine see Cinnarizine/flunarizine

    Newsletter Article 05 February 2013 Pages: 7 - 7

32. Gentamicin see Amikacin/gentamicin

    Newsletter Article 05 February 2013 Pages: 7 - 7

33. Ibuprofen

    Newsletter Article 05 February 2013 Pages: 7 - 7

34. Isotretinoin

    Newsletter Article 05 February 2013 Pages: 7 - 8

35. Isotretinoin/etretinate

    Newsletter Article 05 February 2013 Pages: 8 - 8

36. Lithium interaction

    Newsletter Article 05 February 2013 Pages: 8 - 8

37. Lofepramine

    Newsletter Article 05 February 2013 Pages: 8 - 8

38. Methyldopa

    Newsletter Article 05 February 2013 Pages: 8 - 8

39. Midazolam withdrawal

    Newsletter Article 05 February 2013 Pages: 8 - 8

40. Pentamidine

    Newsletter Article 05 February 2013 Pages: 8 - 8

41. Phenelzine interaction

    Newsletter Article 05 February 2013 Pages: 8 - 9

42. Phenylpropanolamine +; chlorphenamine see Cocaine interaction

    Newsletter Article 05 February 2013 Pages: 9 - 9

43. Plicamycin

    Newsletter Article 05 February 2013 Pages: 9 - 9

44. Prednisolone interaction

    Newsletter Article 05 February 2013 Pages: 9 - 10

45. Rifampicin see Prednisolone interaction

    Newsletter Article 05 February 2013 Pages: 10 - 10

46. Sodium aurothiomalate

    Newsletter Article 05 February 2013 Pages: 10 - 10

47. Solvent abuse

    Newsletter Article 05 February 2013 Pages: 10 - 10

48. Streptokinase

    Newsletter Article 05 February 2013 Pages: 10 - 10

49. Tamoxifen

    Newsletter Article 05 February 2013 Pages: 10 - 10

50. Thyroxine

    Newsletter Article 05 February 2013 Pages: 10 - 11